And we've effected that change with, with the leading U.S. company, Pfizer, the leading European company, AstraZeneca. Last year, we had a wonderful, Last week, rather a wonderful program with a subsidiary of Merck that actually does most of the fertility drugs in this country, that drops those prices. And now, Major, we're using most favored nation drug pricing that catalyze other changes in the healthcare system. (07:52–08:00)
CLAIM
Asserts that a subsidiary of Merck, which produces most fertility drugs in the U.S., has reduced prices.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
